Raltegravir

• Target :

  HIV Protease|||Integrase

• Related Pathways :

  Microbiology/Virology|||Proteases/Proteasome

• Purity :

  >99.99%

• Bioactivity :

  Raltegravir (MK-0518) is a pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION.

• Smiles :

  Cc1nnc(o1)C(=O)NC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C

• Molecular Formula :

  C20H21FN6O5

• Molecular Weight :

  444.42

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  518048-05-0